IBT
International Biotechnology Trust Portfolio holdings
AUM
$297M
This Quarter Return
+9.77%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
–
AUM
$210M
AUM Growth
+$210M
(-19%)
Cap. Flow
-$6.83M
Cap. Flow
% of AUM
-3.24%
Top 10 Holdings %
Top 10 Hldgs %
49.98%
Holding
57
New
3
Increased
11
Reduced
5
Closed
6
Top Buys
1 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$5.21M |
2 |
CELG
Celgene Corp
CELG
|
$4.39M |
3 |
ZGNX
Zogenix, Inc.
ZGNX
|
$4.18M |
4 |
Incyte
INCY
|
$3.92M |
5 |
Exelixis
EXEL
|
$3.53M |
Top Sells
1 |
Neurocrine Biosciences
NBIX
|
$12.1M |
2 |
Biogen
BIIB
|
$10.5M |
3 |
ASXC
Asensus Surgical, Inc.
ASXC
|
$3.82M |
4 |
Verastem
VSTM
|
$3.44M |
5 |
Ionis Pharmaceuticals
IONS
|
$2.97M |
Sector Composition
1 | Healthcare | 92.96% |